The neuroendocrine system and gastrointestinal complications in patients with familial amyloidosis and polyneuropathy

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 9, 1997, Pages 849-854

  El Salhy, Magdy ^a   Nyhlin, Nils ^a   Ando, Yukio ^a   Suhr, Ole ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PREALBUMIN;

AMINO ACID SUBSTITUTION; AMYLOID NEUROPATHY; AMYLOIDOSIS; CAUSE OF DEATH; CONSTIPATION; DIARRHEA; FAMILIAL DISEASE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; GENE MUTATION; HUMAN; INFECTION; MALNUTRITION; NAUSEA; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; REVIEW; VOMITING;

EID: 0030764180     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529709011190     Document Type: Review

References (55)

1. Holmgren G, Holmberg E, Lindström A, Lindström E, Nordenson I, Sandgren O, et al. Familial amyloidotic polyneuropathy in Sweden by RFLP analysis. Clin Genet 1988;33: 176-80.
2. Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand 1976;198 Suppl 590:1-64.
3. 30 carriers in northern Sweden. Discrepancy between carriers frequency and prevalence rate. J Med Genet 1994;31:351-4.
4. Saraiva M, Birkin S, Costa P, Goodman D. Amyloid fibril protein in familial amyloid polyneuropathy, Portugese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest 1984;74:104-19.
5. Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 1983;116:880-8.
6. Bhatia K, Reilly M, Adams D, Davis MB, Hawkes CH, Thomas PK, et al. Transthyretin mutations in British and French patients with amyloid neuropathy. J Neurol Neurosurg Psychiatry 1993; 56:694.
7. Dwulet F, Benson M. Polymorphism of human plasma thyroxin binding prealbumin. Biochem Biophys Res Commun 1983;114: 657-62.
8. Staunton H, Dervan P, Kale R, Linke RP, Kelly P. Hereditary amyloid polyneuropathy in northwest Ireland. Brain 1987;110: 1231-45.
9. Chang CM, Yu YI, Wong M, Ng TH, Woo E, Haung CY. Type I familial amyloid polyneuropathy in Chinese family. Acta Neurol Scand 1989;79:391-6.
10. Feurle G. Pathophysiology of diarrhoea in patients with familial amyloid neuropathy. Digestion 1987;36:13-7.
11. Holt IJ, Harding AE, Middletton L, Chrysostomou G, Said G, King RH, et al. Molecular genetics of amyloid neuropathy in Europe. Lancet 1989;1:524-6.
12. Olofsson B-O. Cardiac involvement in familial amyloidosis with polyneuropathy. Int J Cardiol 1983;4:71-3.
13. Steen L, Ek B. Familial amyloidosis with polyneuropathy. Aspects of relationship between gastrointestinal symptoms. EMG findings, and malabsorption studies. Scand J Gastroenterol 1984;19:480-6.
14. Steen L, Ek B. Familial amyloidosis with polyneuropathy. A long term follow up of 21 patients with special reference to gastrointestinal symptoms. Acta Med Scand 1984;214:387-97.
15. Suhr O, Danielsson A, Steen L. Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of patients with familial amyloidosis with polyneuropathy. Scand J Gastroenterol 1992;27:201-7.
16. Steen L. Gastrointestinal involvement in familial amyloidosis with polyneuropathy. A cliniccal study [thesis]. Umeå Faculty of Medicine: Umeå University, 1983;93:1-46.
17. Suhr O, Danielsson Å, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as a prognostic factors for survival in familial amyloidotic polneuropathy. J Intern Med 1994;235: 479-85.
18. Steen L, Öberg L. Familial amyloidosis with polyneuropathy. Roentgenologic and gastroscopic appearance of gastrointestinal involvement. Am J Gastroenterol 1983;18:961-8.
19. Monterio JG. The digestive system in familial amyloidotic polyneuropathy. Am J Gastroenterol 1973;60:47-59.
20. Ikeda S, Makishita H, Oguchi K, Yanagisawa N, Nagata T. Gastrointestinal amyloid deposition in familial amyloid polyneuropathy. Neurology 1982;32:1364-8.
21. Ikeda S, Yanagisawa N, Hongo M, Ito N. Vagus nerve and celiac ganglion lesions in generalized amyloidosis. A correlative study of familial amyloid polyneuropathy and AL-amyloidosis. J Neurol Sci 1987;79:129-39.
22. Takahashi K, Yi S, Kimura Y, Araki S. Familial amyloidotic polyneuropathy type 1 in Kumamoto, Japan. A clinicopathologic, histochemical, immunohistochemical and ultrastructural study. Hum Pathol 1991;22:519-27.
23. Hofer P-Å, Anderson R. Postmortem findings in familial amyloidosis with polyneuropathy, a study based on six cases from northern Sweden. Acta Pathol Microbiol Scand [A] 1975;83:309-22.
24. Rubenstein A, Yhar M, Mytileneou C, Bajaj K. Peripheral cathecholamin depletion in amyloid autonomic neuropathy. Sinai J Med 1978;45:782-9.
25. El-Salhy M. On the phylogeny of the gastro-entro-pancreatic (GEP) neuroendocrine system. Acta Upsal 1981;385:1-39.
26. Dockary GJ, Walsh JH. Regulatory peptide systems of the gut, an introductory essay. In: Dockary GJ, Walsh JH, editors. Gut peptides biochemistry and physiology. New York: Raven Press, 1994. p. 1-10.
27. Debas TH, Mulvihill SJ. Neuroendocrine design of the gut. Am J Surg 1991;161:243-9.
28. Ekblad E, Håkansson R, Sundler F. Microanatomy and chemical coding of peptides-containing neurone in the digestive tract. In: Daniel E, editor. Neuropeptides function in gastrointestinal tract. Boston: CRC Press, Inc; 1991. p. 131-80.
29. Harvey RF. Hormonal control of gastrointestinal motility. Am J Dig Dis 1975;20:523-39.
30. Allescher H, Ahmed S. Postulated physiological and pathophysiological roles on motility. In: Daniel E, editor. Neuropeptides function in gastrointestinal tract. Boston: CRC Press Inc; 1991. p. 309-400.
31. Mannon P, Taylor IL. The pancreatic polypeptide family. In: Dockary GJ, Walsh JH, editors. Gut peptides biochemistry and physiology. New York: Raven Press; 1994. p. 341-70.
32. Dockary GJ. Substance P and other tachykinins. In: Dockary GJ, Walsh JH, editors. Gut peptides biochemistry and physiology. New York: Raven Press; 1994. p. 401-22.
33. Dockary GJ. Vasoactive intestinal polypeptide and related peptides. In: Dockary GJ, Walsh JH, editors. Gut peptides biochemistry and physiology. New York: Raven Press; 1994. p. 447-72.
34. Qian B-F, Danielsson Å, El-Salhy M. Vagal regulation of the gastrointestinal system. Scand J Gastroenterol 1996;31:529-40.
35. Sjölund K, Sandén G, Håkansson R, Sundler F. Endocrine cells in human intestine. An immunocytochemical study. Gastroenterology 1983;85:1120-30.
36. Buchan A, Polak JM. The classification of the human gastroenteropacreatic endocrine cells. Invest Cell Pathol 1980;3:51-71.
37. El-Salhy M, Grimelius L, Wilander E, Ryberg B, Terenius L, Lundberg JM, et al. Immunocytochemical identification of polypeptide YY (PYY) in the human gastrointestinal tract. Histochemistry 1983;77:15-23.
38. Qian B-F, El-Salhy M, Danielsson Å, Shalaby A, Axelsson H. The effect of unilateral vagotomy on antral endocrine cells in mouse. Histochem J 1997. In press.
39. El-Salhy M, Suhr O. Endocrine cells in rectal biopsy specimens from patients with familial amyloidotic polyneuropathy. Scand J Gastroenterol 1996;31:68-73.
40. Huizinga JD, Pintin-Quezada J. Physiological and pathophysiolgical roles of VIP, somatostatin, opioids, galanin, GRP, and secretin. In: Daniel E, editor. Neuropeptides function in gastrointestinal tract. Boston: CRC Press Inc; 1991. p. 401-28.
41. Jaffe JJ, Martin WR. Opioid analgesics and antagonists. In: Gilman AG, Goodman LS, Rall TW, Murad F, editors. Pharmacological basis of therapeutics. New York: Macmillan; 1985. p. 491-503.
42. Stewart JJ. Temporal effects of morphine on rat intestinal transit. Pharmacology 1984;29:47-54.
43. Plant OH, Miller GH. Effect of morphine and some other opium alkaloids on the muscular activity of the alimentary canal. J. Pharmacol Exp Ther 1926;28:245-52.
44. Blanquet F, Bouvier M, Conella J. Effects of enkephalins and morphine on spontaneous electrical activity and on junction potentials elicited by parasympathetic nerve stimulation in cat and rabbit colon. Br J Pharmacol 1982;77:419-26.
45. Schang JC, Hemond M, Herbert M, Pilote M. How does morphine work on colonic motility? An electromyographic study in the human left and sigmoid colon. Life Sci 1986;38:671-5.
46. Adrian TE, Greenberg GR, Bloom SR. Actions of pancreatic polypeptide in man. In: Bloom SR, Polak JM, editors. Gut hormones. Edinburgh: Churchill Livingstone; 1981. p. 206-12.
47. McDonald TJ. Gastroentropancreatic regulatory peptide structure. An overview. In: Daniel E, editor. Neuropeptides function in gastrointestinal tract. Boston: CRC Press Inc; 1991. p. 19-86.
48. Lin TM, Evans DC, Shaar CJ, Chance RE. Physiological versus pharmacological actions of bovine pancreatic polypeptide on the pancreas, gallbladder, choledochal sphincter and intestine of dogs. In, Myoshi A, editor. Gut peptides, secretion, function, and clinical aspects. Amsterdam: Elsevier Biomedical Press, 1979. p. 175-81.
49. El-Salhy M, Suhr O, Stenling R, Wilander E, Grimelius L. Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut 1994;35:1413-8.
50. Steen L, Stenling R. The relatioship between morphological findings and function of the small intestine in familial amyloidosis with polyneuropathy. Scand J Gastroenterol 1983;18:961-8.
51. Mulholand MW, Debas HT. Physiology and pathology of gastrin. A review. Surgery 1988;103:135-47.
52. Steen L, Holmgren G, Suhr O, Wikström L, Groth C-G, Ericzon B-G. World-wide survey of liver transplantation in patients with familial amyloidotic polyneuropathy. Amyloid Int Exp Clin Invest 199;1. p. 138-42.
53. Suhr O, Holmgren G, Ericzon B-G, Bromeé U, Duraj F, Eleborg L, et al. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 1995;60:933-8.
54. Ericzon B-G, Suhr O, Bromeé U, Holmgren G, Duraj F, Eleborg L, et al. Liver transplantation halts the progress of familial amyloidotic polyneuropathy. Transplantation Proc 1995;27: 1233.
55. Holmgren G, Ericzon B-G, Groh C-G, Steen L, Suhr O, Anderson O, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin anyloidosis. Lancet 1993;341:1113-6.